SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.
Front Pharmacol
; 13: 946348, 2022.
Article
in En
| MEDLINE
| ID: mdl-36105223
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Front Pharmacol
Year:
2022
Document type:
Article